2 years ago
NNOX
AnalystsRoss OsbornRoss Osborn's Stock Forecasts
AnalystsRoss Osborn
Analyst Ranking
Bottom 5%
#5064 out of 5296 analysts
Average Return
-5.87%
Win Rate
30%34 out of 113
Risk vs Reward
Poor
Good
Ross Osborn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prenetics Global LtdPRE | +227.12% | $4.40 | $14.39 | 2024-12-03 - 2025-12-03 | Strong Buy |
Exagen IncXGN | +219.89% | $1.76 | $5.63 | 2024-05-13 - 2025-05-13 | Strong Buy |
Axogen IncAXGN | +203.42% | $4.68 | $14.20 | 2023-09-25 - 2024-09-25 | Strong Buy |
Elutia IncELUT | +199.20% | $1.25 | $3.74 | 2023-09-25 - 2024-09-25 | Strong Buy |
Prenetics Global LtdPRE | +150.76% | $5.93 | $14.87 | 2025-01-15 - 2026-01-15 | Strong Buy |
Ross Osborn Analyst Color
Get additional color on Ross Osborn's coverage of popular stocks
2 years ago
RCEL
2 years ago
NYXH
3 years ago
NNOX
Ross Osborn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cvrx IncCVRX | 4 | Strong Buy | $13.00 | +161.04% | Maintains | 7 months ago |
Prenetics Global LtdPRE | 8 | Strong Buy | $32.00 | +54.22% | Maintains | 8 months ago |
Organogenesis Holdings IncORGO | 4 | Strong Buy | $9.00 | +273.44% | Maintains | 10 months ago |
Lemaitre Vascular IncLMAT | 2 | Hold | $95.00 | +3.35% | Maintains | 10 months ago |
Si Bone IncSIBN | 10 | Strong Buy | $25.00 | +65.34% | Reiterates | 10 months ago |
Mimedx Group IncMDXG | 5 | Strong Buy | $12.00 | +226.09% | Maintains | a year ago |
Bioventus IncBVS | 1 | Strong Buy | $12.00 | +39.53% | Initiates Coverage On | a year ago |
Exagen IncXGN | 6 | Strong Buy | $7.00 | N/A | Maintains | a year ago |
Lucid Diagnostics IncLUCD | 6 | Strong Buy | $2.00 | N/A | Reiterates | a year ago |
Neuropace IncNPCE | 7 | Strong Buy | $17.00 | N/A | Reiterates | a year ago |
Nano X Imaging LtdNNOX | 12 | Strong Buy | $9.00 | N/A | Maintains | a year ago |
Sanara Medtech IncSMTI | 6 | Strong Buy | $46.00 | N/A | Reiterates | a year ago |
Elutia IncELUT | 10 | Strong Buy | $8.00 | N/A | Reiterates | a year ago |
Axogen IncAXGN | 3 | Strong Buy | $24.00 | N/A | Reiterates | a year ago |
Cerus CorpCERS | 4 | Strong Buy | $4.00 | N/A | Reiterates | a year ago |
Anteris Technologies Global CorpAVR | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | a year ago |
Avita Medical IncRCEL | 10 | Strong Buy | $21.00 | N/A | Reiterates | a year ago |
Nyxoah SaNYXH | 4 | Strong Buy | $16.00 | N/A | Reiterates | 2 years ago |
Pacific Biosciences Of California IncPACB | 5 | Strong Buy | $3.50 | N/A | Reiterates | 2 years ago |
Volitionrx LtdVNRX | 3 | Strong Buy | $50.00 | N/A | Reiterates | 2 years ago |
Aspira Women's Health IncAWHL | 5 | Hold | $3.30 | N/A | Reiterates | 2 years ago |
Quantum Cyber NvQUCY | 5 | Strong Buy | $360.00 | N/A | Reiterates | 3 years ago |
Asensus Surgical IncASXC | 2 | Strong Buy | $1.00 | N/A | Reiterates | 3 years ago |
Pavmed IncPAVM | 2 | Hold | $258.30 | N/A | Reiterates | 3 years ago |
Seaspine Holdings CorpSPNE | 1 | Strong Buy | $21.00 | N/A | Assumes | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.